SMTI Sanara MedTech Inc.

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

$31.78
As of 09/16/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Care Facilities
Index country:  USA
Country of incorporation:  USA
IPO date:  04/07/1994
Outstanding shares:  7,626,705
Average volume:  17,847
Market cap:   $234,826,247
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    79957L100
ISIN:        US79957L1008
Sedol:      BJDQMV2
Valuation   (See tab for details)
PE ratio:   -64.69
PB ratio:   6.89
PS ratio:   11.52
Return on equity:   -10.81%
Net income %:   -18.38%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy